Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000482

Drug Information
NameAtenolol    
SynonymsTeno-basan; Jenatenol; NCGC00024566-07; KBio2_004412; D00235; I01-3572; Atenol Gador; CCRIS 4196; Tenolol; EINECS 249-451-7; Atenol-Mepha; BENZENEACETAMIDE, 4-(2-HYDROXY-3-((1-METHYLETHYL)AMINO)PROPOXY)-, (+-)-; Betatop Ge; Atenol Cophar; KBio3_002415; Prenolol; NCGC00015007-07; Benzeneacetamide, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-; Alinor; MLS000069622; Atenol Atid; Corotenol; NCGC00024566-03; Atenol Fecofar; ( inverted question mark)-Atenolol; Benzeneacetamide, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-; Cardaxen; Juvental; Atenol ct; Vascoten; Atenol Stada; KBioGR_000790; AC1Q1QBX; Atcardil; Loten; AC1L1D99; Hypoten; Vericordin; Atenomel; L000116; HMS2090I19; UNII-50VV3VW0TI; 60966-51-0; Hipres; Cuxanorm; Tenoprin; Wesipin; Atenol-Wolff; Duraatenolol; LS-28557; IDI1_000057; AC-11142; Tenoblock; Atenololum; Spectrum4_000435; Tenidon; Atenol NM Pharma; NCGC00015007-13; Apo-Atenolol; Evitocor; Anselol; SAM002564193; Lopac0_000121; HMS2092D19; Atenolol (JP15/USP/INN); Atenol Trom; 1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol; Noten; ICI66082; Serten; MLS001304038; D001262; Atenil; Tenormin (TN); Premorine; (+/-)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide; ICI 66082; DivK1c_000057; Normalol; Myocord; Blocotenol; Acetamide,2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl); Acetamide, 2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)-; Ormidol; CPD000036768; SPBio_001482; Servitenol; Aircrit; Atecard; BSPBio_002915; Atenol acis; 4-[2'-Hydroxy-3'-(isopropylamino)propoxy]phenylacetamide; 2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide; Tenormine [French]; METKIMKYRPQLGS-UHFFFAOYSA-; Atenololum [INN-Latin]; A 7655; Atenblock; Atenol Nordic; Felo-Bits; Prinorm; Atenol AL; Tenormine; Stermin; Lotenal; 2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide; Atenol Genericon; Xaten; DB00335; (+-)-4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide; 2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide; Oraday; Uniloc; HMS1569L13; Spectrum5_001509; Atendol; MolPort-001-792-717; 4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide; STK528649; LS-9707; Atenol-ratiopharm; Tredol; 2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide; ARONIS23884; Neatenol; Prenormine; NCGC00024566-05; BIM-0050109.0001; Atenol PB; EU-0100121; duratenol; ICI-66082; EINECS 262-544-7; 4-[2 -Hydroxy-3 -(isopropylamino)-propoxy]phenylacetamide; (+-)-Atenolol; Betablok; NCGC00024566-04; Atenol Heumann; AKOS005111050; 2-[4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]acetamide; Atenol; Tensotin; Spectrum_001364; Atenol von ct; CHEMBL24; Atenol Quesada; Spectrum3_001448; 29122-68-7; Farnormin; Plenacor; InChI=1/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18); HMS1921H09; Ibinolo; A7655_SIGMA; Cardiopress; Panapres; Antipressan; Atenol GNR; Spectrum2_001411; Tensimin; KBio2_006980; Atenet; KBioSS_001844; 2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide; HSDB 6526; (1)-2-(4-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide; Betacard; Betasyn; (?)-Atenolol; BRN 2739235; Tenormin; Atehexal; MLS001066372; KBio2_001844; Seles beta; Selobloc; Atenol Tika; MLS001074163; Aterol; Atenolin; benzeneacetamide, 4-[2'-hydroxy-3;-[(1-methylethyl)amino]propoxy]-; Blokium; NCGC00024566-06; Atenol 1A pharma; Tenobloc; BRD-A20239487-001-02-5; KBio1_000057; Normiten; NINDS_000057; 2-(4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl)acetamid; Atenolol [USAN:INN:BAN:JAN]; CHEBI:2904; atenolol; CID2249; SPECTRUM1501127; SMR000036768; Unibloc; Ateni; Scheinpharm Atenol; ICI 66,082; Altol; Atereal; Oprea1_448775; BB_SC-1519; Internolol; Atenol MSD; Lo-ten; HMS500C19    
IndicationHypertensionApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntihypertensive Agents    
CAS NumberCAS 29122-68-7
FormularC14H22N2O3    
PubChem Compound IDCID 2249.    
PubChem Substance IDSID 176216.    
SuperDrug ATC IDC07AB03;    
SuperDrug CAS ID029122687;    
TargetBeta-1 adrenergic receptorAntagonist[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 072303 To Reference
Ref 2Prediction and experimental validation of acute toxicity of beta-blockers in Ceriodaphnia dubia. Environ Toxicol Chem. 2005 Oct;24(10):2470-6. To Reference
Ref 3Current therapeutic uses and potential of beta-adrenoceptor agonists and antagonists. Eur J Clin Pharmacol. 1998 Feb;53(6):389-404. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543